Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism Chk2 inhibitors(Checkpoint kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Arum Therapeutics, Inc.Startup |
Active Organization Arum Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | KR | Arum Therapeutics, Inc.Startup | 22 Mar 2024 |
Triple Negative Breast Cancer | Preclinical | KR | Arum Therapeutics, Inc.Startup | 22 Mar 2024 |